JPWO2020023310A5 - - Google Patents
Download PDFInfo
- Publication number
- JPWO2020023310A5 JPWO2020023310A5 JP2021526403A JP2021526403A JPWO2020023310A5 JP WO2020023310 A5 JPWO2020023310 A5 JP WO2020023310A5 JP 2021526403 A JP2021526403 A JP 2021526403A JP 2021526403 A JP2021526403 A JP 2021526403A JP WO2020023310 A5 JPWO2020023310 A5 JP WO2020023310A5
- Authority
- JP
- Japan
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201862701467P | 2018-07-20 | 2018-07-20 | |
| US62/701,467 | 2018-07-20 | ||
| PCT/US2019/042597 WO2020023310A1 (en) | 2018-07-20 | 2019-07-19 | Compositions of fcrn antibodies and methods of use thereof |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2021531346A JP2021531346A (ja) | 2021-11-18 |
| JPWO2020023310A5 true JPWO2020023310A5 (ru) | 2022-06-20 |
| JP7457704B2 JP7457704B2 (ja) | 2024-03-28 |
Family
ID=69180697
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2021526403A Active JP7457704B2 (ja) | 2018-07-20 | 2019-07-19 | Ｆｃｒｎ抗体の組成物およびその使用の方法 |
Country Status (15)
| Country | Link |
|---|---|
| US (1) | US20210299255A1 (ru) |
| EP (1) | EP3826641A4 (ru) |
| JP (1) | JP7457704B2 (ru) |
| KR (1) | KR20210105872A (ru) |
| CN (1) | CN113301903A (ru) |
| AU (1) | AU2019312139A1 (ru) |
| BR (1) | BR112021001017A2 (ru) |
| CA (1) | CA3106669A1 (ru) |
| CR (1) | CR20210088A (ru) |
| EA (1) | EA202190335A1 (ru) |
| IL (1) | IL280280A (ru) |
| JO (2) | JOP20210015A1 (ru) |
| MX (1) | MX2021000790A (ru) |
| SG (1) | SG11202100420UA (ru) |
| WO (1) | WO2020023310A1 (ru) |
Families Citing this family (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| LT3250610T (lt) | 2015-01-30 | 2023-09-25 | Momenta Pharmaceuticals, Inc. | Fcrn antikūnai ir jų panaudojimo būdai |
| KR20200098604A (ko) | 2017-12-13 | 2020-08-20 | 모멘타 파머슈티컬스 인코포레이티드 | FcRn 항체 및 이의 사용 방법 |
| JP2024517087A (ja) * | 2021-04-12 | 2024-04-19 | モメンタ ファーマシューティカルズ インコーポレイテッド | 小児重症筋無力症を治療するための組成物及び方法 |
| CN116539488B (zh) * | 2023-05-11 | 2023-11-24 | 中国食品药品检定研究院 | 一种体外评价生物制品稳定性的方法、系统及设备 |
Family Cites Families (10)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| KR20110091822A (ko) * | 2002-02-14 | 2011-08-12 | 추가이 세이야쿠 가부시키가이샤 | 항체함유 용액제제 |
| EP1865986B1 (en) * | 2005-03-08 | 2016-02-17 | Pfizer Products Inc. | Anti-ctla-4 antibody compositions |
| WO2009124294A2 (en) * | 2008-04-05 | 2009-10-08 | Lpath, Inc. | Pharmaceutical compositions for binding sphingosine-1-phosphate |
| US20110293605A1 (en) * | 2008-11-12 | 2011-12-01 | Hasige Sathish | Antibody formulation |
| US20130323242A1 (en) * | 2012-06-01 | 2013-12-05 | Ophthotech Corp. | Compositions comprising an anti-pdgf aptamer and a vegf antagonist |
| US9844594B2 (en) * | 2012-12-18 | 2017-12-19 | Merck Sharp & Dohme Corp. | Liquid formulations for an anti-TNF α antibody |
| ES2607489T3 (es) * | 2014-05-23 | 2017-03-31 | Ares Trading S.A. | Composición farmacéutica líquida |
| LT3250610T (lt) * | 2015-01-30 | 2023-09-25 | Momenta Pharmaceuticals, Inc. | Fcrn antikūnai ir jų panaudojimo būdai |
| WO2017015622A2 (en) * | 2015-07-22 | 2017-01-26 | Scholar Rock, Inc | Gdf11 binding proteins and uses thereof |
| HRP20240048T1 (hr) * | 2016-07-29 | 2024-03-29 | Momenta Pharmaceuticals, Inc. | Fcrn antitijela i postupci njihove uporabe |
-
2019
- 2019-07-19 BR BR112021001017-3A patent/BR112021001017A2/pt unknown
- 2019-07-19 MX MX2021000790A patent/MX2021000790A/es unknown
- 2019-07-19 CA CA3106669A patent/CA3106669A1/en active Pending
- 2019-07-19 WO PCT/US2019/042597 patent/WO2020023310A1/en unknown
- 2019-07-19 EA EA202190335A patent/EA202190335A1/ru unknown
- 2019-07-19 JO JOP/2021/0015A patent/JOP20210015A1/ar unknown
- 2019-07-19 US US17/260,318 patent/US20210299255A1/en active Pending
- 2019-07-19 AU AU2019312139A patent/AU2019312139A1/en active Pending
- 2019-07-19 CN CN201980061788.8A patent/CN113301903A/zh active Pending
- 2019-07-19 CR CR20210088A patent/CR20210088A/es unknown
- 2019-07-19 SG SG11202100420UA patent/SG11202100420UA/en unknown
- 2019-07-19 KR KR1020217003706A patent/KR20210105872A/ko active Search and Examination
- 2019-07-19 JP JP2021526403A patent/JP7457704B2/ja active Active
- 2019-07-19 JO JOP/2021/0014A patent/JOP20210014A1/ar unknown
- 2019-07-19 EP EP19840439.4A patent/EP3826641A4/en active Pending
-
2021
- 2021-01-19 IL IL280280A patent/IL280280A/en unknown